Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Margot Tesselaar's publication output changed over time?
ScholarIQpublication output · 2004–2023
Output grew0% over the shown period — from 1 works in 2004 to 1 in 2023.
1
1
2
2
1
1
2
1
20042005200720092011201520222023
What are the most-cited papers on Margot Tesselaar?
ScholarIQmost cited works
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiří Tomášek, Markus Raderer, Harald Lahner, Maurizio Voi, Lida Pacaud, Nicolas Rouyrre, Carolin Sachs, Juan W. Valle, Gianfranco Delle Fave, Eric Van Cutsem, Margot Tesselaar, Yasuhiro Shimada, Do‐Youn Oh, Jonathan Strosberg, Matthew H. Kulke, Marianne Pavel
The Lancet. 20151,272 Citations
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Miriam Koopman, Ninja Antonini, Joep Douma, J. Wals, Aafke H. Honkoop, Frans Erdkamp, Robert S. de Jong, C. J. Rodenburg, Gerard Vreugdenhil, O. J. L. Loosveld, Aart van Bochove, Harm Sinnige, Geert-Jan Creemers, Margot Tesselaar, P. H. Th. J. Slee, M.J.B.P. Werter, Linda Mol, Otilia Dalesio, Cornelis J.A. Punt
The Lancet. 2007632 Citations
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
Margot Tesselaar, Fred P.H.T.M. Romijn, I K van der Linden, Frans A. Prins, Rogier M. Bertina, S. Osanto
S164469042. 2007537 CitationsOPEN ACCESS
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
Jean Louis Lefèbvre, Frédéric Rolland, Margot Tesselaar, É. Bardet, C. René Leemans, Lionnel Geoffrois, P. Hupperets, Luigi Barzan, D. De Raucourt, Dominique Chevalier, Lisa Licitra, F Lunghi, Roger Stupp, Denis Lacombe, Jan Bogaerts, Jean-Claude Horiot, J. Bernier, Jan B. Vermorken, for the EORTC Head and Neck Cancer Cooperative Group and the EORTC Radiation Oncology Group
JNCI Journal of the National Cancer Institute. 2009282 CitationsOPEN ACCESS
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
H.H. Hartgrink, Cornelis J.�H. van de Velde, Hein Putter, Ilfet Songun, Margot Tesselaar, Elma Meershoek‐Klein Kranenbarg, J.E. de Vries, J. Wils, Jaap van der Bijl, J. Han van Krieken
European Journal of Surgical Oncology. 2004199 Citations
Related on ScholarIQ
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
Paper
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Paper
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
Paper
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
Paper
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
Paper
Deep vein thrombosis associated with central venous catheters – a review
Paper